- Science
- Global
AI-generated compounds hit specific cell types and outperform conventional screening
- June 6, 2026 at 7:40 PM
- 7 views
The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse the course of a disease. However, in many pathologies, such a target does not always exist or is not sufficiently characterized.
Originally published at Phys.org